Fundz

Co-Diagnostics, Inc. Announces Completion Of The Acquisition Of All Assets And Intellectual Property Related To At-Home/Point-Of-Care Platform

PUBLIC · CODXDec 31, 2021

Acquiring Company

Co-Diagnostics, Inc.

Acquired Company

Assets

Salt Lake CityManufacturingBiotechnologyHealth CareScience And EngineeringHealth Diagnostics

Description

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed the acquisition of Idaho Molecular Inc. and Advanced Conceptions, Inc. for nearly 4.72 million shares of the Company's stock, plus additional common warrants totaling 465,000, providing Co-Diagnostics with all existing and future assets and intellectual property related to the Company's upcoming at-home/point-of-care diagnostic device.

Quick answer

Co-Diagnostics, Inc. is acquiring Assets, announced December 31, 2021. Co-Diagnostics, Inc. is based in Salt Lake City, Utah, United States.

How much did Co-Diagnostics, Inc. pay for Assets?
The deal value was not disclosed.
What does Co-Diagnostics, Inc. do?
At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications, especially to..
Where are Co-Diagnostics, Inc. and Assets based?
Co-Diagnostics, Inc. is based in Salt Lake City, Utah, United States.

Source: Fundz verified event record.

Who to call at Co-Diagnostics, Inc., and when

When Co-Diagnostics, Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Co-Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Co-Diagnostics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Co-Diagnostics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Co-Diagnostics, Inc.

Location

2401 South Foothill Drive

Salt Lake City, Utah, United States

About

At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications, especially to those regions where pricing is paramount. Our proprietary molecular diagnostics technology is paving the way for innovation in disease detection and life sciences research through our enhanced detection of genetic material. Because we own our platform, we are able to accomplish this faster and more economically, allowing for wider margins while still positioning Co-Diagnostics to be the worldwide low-cost leader of molecular diagnostics services.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Co-Diagnostics, Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Co-Diagnostics, Inc.'s next move

Learn about Strategic plan

Frequently asked

Who acquired Assets?

Assets was acquired by Co-Diagnostics, Inc., based in Salt Lake City. The deal was reported on December 31, 2021. Co-Diagnostics, Inc. is publicly traded (CODX) and operates in Manufacturing.

When did Co-Diagnostics, Inc. acquire Assets?

Co-Diagnostics, Inc.'s acquisition of Assets was reported on December 31, 2021. Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed the acquisition of Idaho Molecular Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Assets do?

Assets is the company acquired in this transaction. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.